Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - DEPRECIATION & AMORTIZATION
Depreciation & Amortization KALV - KalVista Pharmaceuticals, Inc.
816 K
LAST VALUE
20.28%
2 YEAR CAGR
16.64%
5 YEAR CAGR
40.62%
10 YEAR CAGR